High-dose dexamethasone modulates serum cytokine profile in patients with primary immune thrombocytopenia
Authors:
- 1 July 2014
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 160 (1) , 33-38
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81170473)
- Shanghai Health Bureau Funding (20124223)
This publication has 27 references indexed in Scilit:
- Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitisNeurobiology of Disease, 2013
- Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with vitiligoGenetics and Molecular Research, 2013
- High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcγ receptors on monocytes in patients with primary immune thrombocytopeniaBlood, 2011
- High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpuraHaematologica, 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpuraBlood, 2008
- Pathogenesis of Rheumatoid Arthritis: Targeting CytokinesAnnals of the New York Academy of Sciences, 2005
- Effect of plasma exchange on cytokines measured by multianalyte bead array in thrombotic thrombocytopenic purpuraAmerican Journal of Hematology, 2005
- Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune responseBlood, 2004
- Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose DexamethasoneNew England Journal of Medicine, 2003